1 07, 2019

Minister opens new Business Innovation Centre for life sciences start-ups

2019-07-01T18:03:10+00:00July 1st, 2019|

The new development complements the University’s existing Business Innovation Centres which are home to 52 early-stage companies. The University’s focus with the new Business Innovation Centre – North at Dangan Business Park is in driving Life Sciences research and innovation to develop services and solutions that demonstrably improve outcomes for patients through solutions that save [...]

9 04, 2019

Clinical Trial Investigates Orbsen Therapeutics’ ORBCEL-C™ Immunotherapy as Treatment for two Autoimmune Liver Diseases

2019-04-09T20:54:20+00:00April 9th, 2019|

Orbsen Therapeutics, a biotechnology company focused on the development and commercialization of first-in-class stromal cell immunotherapies, announced its second generation immunotherapy ORBCEL-C™ is being administered to patients participating in MERLIN, a multi-site United Kingdom-based clinical trial to determine the therapy’s safety and effectiveness in treating two types of chronic autoimmune liver diseases. “Orbsen’s product [...]

2 04, 2019

Orbsen Therapeutics Moves Into New Headquarters in Galway, Ireland

2019-04-03T21:28:42+00:00April 2nd, 2019|

Orbsen Therapeutics Moves Into New Headquarters in Galway, Ireland Progress in company’s product pipeline requires move to larger facilities (2 April 2019) Galway, Ireland — Orbsen Therapeutics, a biotechnology company focused on the discovery, development and commercialization of first-in-class stromal cell immunotherapies, announced it will move its base of operations from the National University [...]

2 10, 2018

Orbsen Therapeutics’ NEPHSTROM Clinical Trial Underway at Four European Union Locations

2019-04-09T20:49:47+00:00October 2nd, 2018|

Orbsen Therapeutics’ NEPHSTROM Clinical Trial Underway at Four European Union Locations Patients with diabetic kidney disease are being treated with a breakthrough stromal cell immunotherapy (October 2, 2018) Galway, Ireland — Orbsen Therapeutics, a biotechnology company focused on the discovery, development and commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation [...]

22 02, 2018

Irish Times Features

2018-03-06T20:17:18+00:00February 22nd, 2018|

NUI Galway leads stem-cell research on diabetic kidney disease, €1.7m in funding for twenty new high-potential research projects announced, Scientific research projects get €1.7million funding boost, Orbsen Therapeutics to take part in €6m liver disease clinical trial, Innovation Awards profile: Orbsen Therapeutics – Stem cell research, The cream of start-ups, college spin-offs and smooth operators. […]

22 02, 2018

Dr. Larry Couture Named CEO Of Orbsen Therapeutics

2018-03-15T12:35:48+00:00February 22nd, 2018|

NEW YORK, Sept. 6, 2016 /PRNewswire/ — Dr. Jack Kavanaugh, Chairman of Orbsen Therapeutics (http://www.orbsentherapeutics.com/), announced today the appointment of Larry Couture, PhD, as CEO. “Dr. Couture brings a remarkable background in cellular and genetic therapeutics with industry leading experience in both the scientific and business development of leading edge therapeutics,” said Kavanaugh. He added, “His industry experience at [...]

22 02, 2018

Orbsen Therapeutics Receives Approval from European Regulators for Clinical Trial of Breakthrough Cell Therapy for Diabetic Kidney Disease

2018-03-06T20:17:32+00:00February 22nd, 2018|

NEW YORK–(BUSINESS WIRE)–Orbsen Therapeutics (www.orbsentherapeutics.com) breakthrough stromal cell immunotherapy, OBRCEL-M™, developed as part of NEPHSTROM, a European Union Horizon 2020-funded research project coordinated by NUI Galway, has been approved to begin testing in a randomised, double blind, and placebo-controlled European clinical trial to treat diabetic kidney disease. […]

25 04, 2016

Dr. Jack Kavanaugh Named Chairman of Orbsen

2018-03-15T12:35:48+00:00April 25th, 2016|

Dr. Jack Kavanaugh, an internationally recognized surgeon and businessman who has spearheaded the commercialization of cellular therapies and emerging biotechnology firms has been named Chairman of Orbsen Therapeutics, it was announced today by Dr. Chris Coughlan, Founding Director. “Orbsen Therapeutics has developed cutting edge stem cell technology and is poised to become a leader in [...]

1 12, 2015

Orbsen Awarded 6 Million Euros to Test Cell Therapy for Diabetic Kidney Disease

2018-03-15T12:35:48+00:00December 1st, 2015|

8 June 2015: TheJournal.ie: “NUI Galway spin-out company Orbsen Therapeutics used patented technology to discover the stromal cell therapy, which uses cells purified from healthy donor bone marrow. The four-year research project will see some 48 patients taking part in clinical trials in Galway, Belfast, Birmingham and Bergamo to test the treatment.” […]